Efficacy and Safety of Tumor Necrosis Factor Inhibitors in Acute Generalized Pustular Psoriasis

被引：40
|
作者：
Viguier, Manuelle [1 ,9 ]
Aubin, Francois [2 ,3 ,9 ]
Delaporte, Emmanuel [4 ]
Pages, Cecile
Paul, Carle [5 ,9 ]
Beylot-Barry, Marie [6 ,7 ,9 ]
Goujon, Catherine [8 ,9 ]
Rybojad, Michel
Bachelez, Herve [9 ,10 ]
机构：
[1] Univ Paris Diderot, Hop St Louis, AP HP, Serv Dermatol, F-75475 Paris 10, France
[2] Univ Franche Comte, EA 3181, IFR 133, F-25030 Besancon, France
[3] CHU Besancon, F-25030 Besancon, France
[4] Univ Lille 2, Ctr Hosp Reg Univ, Lille, France
[5] Univ Toulouse 3, Hop Larrey, CHU, F-31062 Toulouse, France
[6] Univ Bordeaux 2, EA 2406, F-33076 Bordeaux, France
[7] CHU, Hop Haut Leveque, Serv Dermatol, Bordeaux, France
[8] Ctr Hosp Lyon Sud, Immunol Clin, Lyon, France
[9] Soc Francaise Dermatol, Grp Rech Psoriasis, Paris, France
[10] Hop Necker Enfants Malad, INSERM, U781, Paris, France
来源：
ARCHIVES OF DERMATOLOGY | 2012年 / 148卷 / 12期
关键词：
D O I：
10.1001/2013.jamadermatol.80
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：1423 / 1425
页数：3
相关论文
共 50 条
  • [1] Generalized pustular psoriasis treated with inhibitors of tumor necrosis factor: Report of three cases
    Alcantara-Gonzalez, Javier
    Fleta-Asin, Beatriz
    Alonso-Castro, Leticia
    Teresa Truchuelo-Diez, Maria
    Garate-Ayastuy, Mayte
    Jimenez-Gomez, Natalia
    Jaen-Olasolo, Pedro
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 66 (04) : AB193 - AB193
  • [2] Prurigo nodularis in a patient with pustular psoriasis, treated with tumor necrosis factor inhibitors
    Anahuati, Ana Paula Orozco
    Hernandez, Miguel Angel Cardona
    Franco, Gisela Navarrete
    Gonzalez, Maribet Gonzalez
    Garcia, Cesar Alfonso Maldonado
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB245 - AB245
  • [3] A Case of Tumor Necrosis Factor-α Inhibitors-induced Pustular Psoriasis
    Park, Jae-Jeong
    Lee, Seung-Chul
    ANNALS OF DERMATOLOGY, 2010, 22 (02) : 212 - 215
  • [4] Comparison of the Safety and Efficacy of Tumor Necrosis Factor Inhibitors and Interleukin-17 Inhibitors in Patients With Psoriasis
    Green, Lawrence J.
    Yamauchi, Paul S.
    Kircik, Leon H.
    JOURNAL OF DRUGS IN DERMATOLOGY, 2019, 18 (08) : 776 - 788
  • [5] Tumor necrosis factor inhibitor - induced pustular psoriasis?
    Heymann, Warren R.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 56 (02) : 327 - 329
  • [6] Biologic Therapy in Psoriasis (Part I): Efficacy and Safety of Tumor Necrosis Factor- α Inhibitors
    Campanati, Anna
    Molinelli, Elisa
    Brisigotti, Valerio
    Offidani, Annamaria
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2017, 18 (12) : 945 - 963
  • [7] Increased serum soluble Fas, tumor necrosis factor α and interleukin 6 concentrations in generalized pustular psoriasis
    Seishima, M
    Seishima, M
    Takemura, M
    Saito, K
    Kitajima, Y
    DERMATOLOGY, 1998, 196 (03) : 371 - 372
  • [8] Efficacy and safety of spesolimab for the management of generalized pustular psoriasis: a drug safety evaluation
    Potestio, Luca
    Camela, Elisa
    Cacciapuoti, Sara
    Martora, Fabrizio
    Guerriero, Luigi
    Fornaro, Luigi
    Ruggiero, Angelo
    Megna, Matteo
    EXPERT OPINION ON DRUG SAFETY, 2023, 22 (11) : 1003 - 1010
  • [9] Tumor Necrosis Factor Inhibitors in Psoriasis: An Update
    Kerdel, Francisco A.
    Strober, Bruce E.
    SEMINARS IN CUTANEOUS MEDICINE AND SURGERY, 2014, 33 : S31 - S36
  • [10] Safety and Tolerability of Tumor Necrosis Factor-α Inhibitors in Psoriasis: A Narrative Review
    Ashley L. Semble
    Scott A. Davis
    Steven R. Feldman
    American Journal of Clinical Dermatology, 2014, 15 : 37 - 43
12345